Aurobindo Pharma LtdNSE: AUROPHARMA

Press Release Apr 07 2026

· Issued by Aurobindo Pharma Ltd

Filed with NSE · · 3 pages · English

On 6ix: 6ix.com/news/press-release-apr-07-2026-20

Release

Aurobindo Pharma Limited has informed the Exchange regarding a press release dated April 07, 2026, titled "Aurobindo Pharma receives USFDA approval for Dapagliflozin and Metformin Hydrochloride Extended-Release Tablets".

Aurobindo Pharma Ltd on 6ix

Earlier from Aurobindo Pharma

Later from Aurobindo Pharma

All Aurobindo Pharma news releases